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Workers check pollution levels at a chemical dumpsite in Ohio. Concern about a link 
between chemicals and cancer has prompted a search by Humphrey Center investigators 
for a better understanding of the problem. 
iiibiuc. lUKing uuil at liie cancer threat 
posed by chemicals in the environment 
In recent months, intense public attention has focused on the prob-
lem of toxic chemicals, especially chemical wastes, in the environ-
ment. 
Along with the heightened concern about environmental chemicals 
has come renewed anxiety about their cancer-causing potential. Yet 
in fact, very little is known about how much cancer results from 
human exposure to toxic chemicals in food, water, the air, the soil or 
wherever people may come in contact with them. 
Research now under way at the Hubert H . Humphrey Cancer Re-
search Center, though, shows promise of demonstrating how chemi-
cals from outside the body affect the reproductive machinery of hu-
man cells—and may thereby help to shed light on the connection 
between such chemicals and cancer. 
At the same time, investigators at the Center are developing new 
techniques to protect the public against the effects of the most com-
mon kinds of environmental chemicals. 
The story of these two fascinating research ventures begins on 
page 3. 
Dedication, awards 
ceremonies set 
for early October 
The dedication of BUSM's new Cen-
ters for Advancement i n Health and 
Medicine, of which the Humphrey 
Center's headquarters forms a part, 
is scheduled for Oct. 3. 
The seven-story structure, which 
previously served as the Boston 
City Hospital Outpatient Building, 
has been totally renovated. The 
Center's headquarters w i l l be on the 
top floor. Other research units 
w i t h i n the School of Medicine w i l l 
occupy the various other floors. 
Presentation of this year's H u m -
phrey Cancer Center Awards w i l l 
take place the same day as the dedi-
cation, said Isaac M . Taylor, M . D . , 
associate director of the Center. 
These awards are given annually to 
honor scientists, political figures, 
philanthropists and others w h o 
have been major contributors to the 
fight against cancer. 
The awards w i l l be made during a 
breakfast on the lawn of the School 
of Medicine. Sen. Mark Hatfield, an 
Oregon Republican and a strong ad-
vocate of federal support for bio-
medical research i n the U.S. Con-
gress, w i l l be the keynote speaker. 
Later that day, there w i l l be a 
dedication ceremony for the Cancer 
Center's headquarters and for other 
components of the School of Medi-
cine's new research facility. 
A t the time of the dedication, 
those who have supported creation 
of the Center's new home w i l l be 
honored, w i t h special recognition 
for major donors. Recently added 
to the list of such donors were Alan 
continued on page 2 
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FROM T H E D I R E C T O R 
Dear Friends, 
The focus of this issue of The Hum-
phrey Center Report is environmental 
contaminants and cancer. It is a 
subject about which relatively little 
is k n o w n . Most of us i n the field ac-
cept the hypothesis that the sub-
stantial majority of cancers, 80 per-
cent or more, are caused by 
environmental factors. As used 
here, however, the term encompas-
ses much more than what is com-
monly thought of as the "environ-
ment": It covers the f u l l range of 
carcinogens, f rom tobacco smoke to 
ultra-violet l ight to cancer-causing 
chemicals i n food and elsewhere. 
For a few of these factors, our 
base of information is quite exten-
sive. We have a tremendous 
amount of evidence af f i rming an as-
sociation between smoking and 
lung cancer. I n other areas, though, 
our knowledge is very l imited. For 
example, we have some animal data 
indicating that polychlorinated bi -
phenyls (PCBs), a common environ-
mental contaminant, cause cancer. 
We have no real idea, however, of 
the extent to which PCBs and other 
toxic chemicals may be responsible 
for cancer rates among exposed h u -
man populations. 
The lack of knowledge about is-
sues like these, which are of intense 
concern from a public-health stand-
point, is unfortunate. Yet i t should 
not be cause for undue pessimism. 
In many respects, we are at a stage 
w i t h carcinogens that is not greatly 
different f rom that of our forebears 
i n the mid-19th century w i t h regard 
to infectious agents. A t that time, 
physicians were not even aware 
that many diseases are caused by 
microorganisms, such as bacteria 
and viruses. Yet w i t h i n a few de-
cades, tremendous progress had 
been made i n the industrialized 
countries against diseases like ty-
phoid and cholera. 
There is, of course, a need for 
caution i n drawing parallels be-
tween infectious diseases and can-
cer. Understanding and dealing 
w i t h carcinogenesis presents a 
much more difficult challenge than 
do most infectious ailments. 
Nevertheless, real progress is 
being made, thanks i n significant 
part to the work being done by i n -
vestigators at this Center. A n d 
while the new knowledge that we 
are acquiring does not promise mir-
acle solutions, I believe that it does 
offer the long-range prospect of ma-
jor inroads against cancers induced 
by toxic chemicals and similar car-
cinogens. 
W i t h our new headquarters 
nearly completed, it gives me great 
pleasure to express m y appreciation 
to the many persons who have sup-
ported this important undertaking 
i n recent months. I 'd like to offer 
special thanks to Alan and Sybil 
Edelstein, and to Dr. Armand Ham-
mer, for their major gifts. I n addi-
t ion, I once again wish to express 
my gratitude to A i d for Cancer Re-
search. I n a major gift last year, that 
dedicated group supported creation 
of the Hybridoma Research Labora-
tory, and the organization recently 
contributed a Liquid H i g h Perfor-
mance Chromatography system for 
the laboratory of our deputy direc-
tor. Dr. Herbert Wotiz. 
Regards, 
Paul H . Black, M . D . 
Dedication... 
continued from page 1 
and Sybil Edelstein of Newton, 
Mass., who are supporting the crea-
tion of a faculty office i n the head-
quarters. The Center also has re-
ceived another major gift f rom 
Armand Hammer, M . D . , the chair-
man of the Occidental Petroleum 
Corp. His donation w i l l support a 
hybridoma clinical research facility 
at the Center. Dr. Hammer's previ-
ous donation, announced last year 
during the Humphrey Cancer Cen-
ter Awards ceremony, also was i n 
support of hybridoma work . 
Meanwhile, noted Taylor, renova-
tion of the headquarters is on 
schedule, which means Center 
members should be occupying their 
new offices and laboratories wel l be-
fore the dedicat ion.• 
Center Director Paul H. Black, M.D., and construction supervisor James Woodbury discuss 
progress on tumor-cell biology laboratories, which will be located in Cancer Center's new 
headquarters. (Photo by Bradford F. Herzog.) 
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John Groopman, Ph.D. (seated) and David Ozonoff, M.D., look over data from experiments 
associated with effort to identify linkages between chemicals and human DNA. (Photo by 
Bradford F. Herzog.) 
Humphrey Center investigators 
are seeking to shed light on the 
chemical-cancer connection 
A chemical dumpsite is identified in a 
community. Citizens who live close to 
the site raise an outcry. Politicians de-
mand government action. Health offi-
cials, after a preliminary analysis, an-
nounce plans for a major study aimed at 
finding out whether the chemicals have 
affected the health of those living near 
the site. 
It's a scene that has been played out 
dozens of times i n communities 
around the country i n recent years. 
Often, the start of the health-effects 
study marks a distinct d imming of 
the media spotlight that has been 
focused on the site. Many of those 
not directly affected doubtless as-
sume that the study w i l l provide 
definitive answers about the effects 
the chemicals have had on those ex-
posed. But w i l l it? 
Almost certainly not, said H u m -
phrey Center member David Ozon-
off, M . D . , an associate professor of 
socio-medical sciences and commu-
nity medicine, and chief of the En-
vironmental Health Section at 
BUSM's School of Public Health. 
In fact, said Ozonoff, epidemio-
logical studies seldom can provide 
clearcut answers about the health 
impacts of chemical dumps. A m o n g 
the reasons are: 
• The most informative kinds of 
epidemiological studies are those i n 
which a group's health can be mon-
itored from the outset of its mem-
bers' exposure to a potential health 
threat—something that's clearly not 
possible i n most chemical dumpsite 
controversies, where public concern 
often develops years after the 
dumping occurred. 
• As a rule, relatively few people 
are exposed to the chemical wastes, 
meaning that there w i l l be too few 
cases of specific types of health 
problems to permit definitive con-
clusions about their causes. 
• It's often very difficult to get an 
accurate picture of other factors that 
may have affected the group's 
health, such as occupational expo-
sures. 
"The most serious problem, 
though," said Ozonoff, "is some-
thing called 'recall bias.' If you live 
near a dumpsite that you believe is 
going to give you headaches, and 
you get a headache, you're going to 
remember i t . If you live somewhere 
else and you get a headache, you 
probably won' t remember i t . This is 
an extremely difficult problem to 
deal w i t h , especially if there has 
been a lot of publicity about the 
site." 
Despite these obstacles, Ozonoff 
said, it's often possible to trace the 
connections between environmental 
chemicals and such short-term 
health effects as headaches, skin 
rashes and nausea. 
When the issue, though, is long-
term health problems—and for can-
cer, there normally is a lag of many 
years between exposure to a carcin-
ogen and the first clinical signs of 
the disease—the task of trying to 
make connections is much tougher. 
"You may be able to tell whether 
people have been exposed to carcin-
ogens by measuring air and water 
samples," said the epidemiologist, 
"but to f ind out if those carcinogens 
are actually producing cancer, you 
need both large populations, and 20 
or 30 years. Usually, you don't have 
either one." 
The search for linkages 
between chemicals and DNA 
To overcome the inherent limits of 
present-day epidemiological tech-
niques, Humphrey Center investiga-
tors are looking for early warning 
signs that chemicals may be posing 
long-term health problems. 
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The specific goal of the research, 
said Ozonoff, is to identify linkages 
between environmental chemicals 
and the genetic material—the 
D N A — i n cells. These linkages, 
k n o w n as D N A adducts, have been 
found i n animal tissues exposed to 
chemicals i n the laboratory. But the 
Humphrey Center research group 
wants to show that the adducts also 
can be identified i n people exposed 
to chemicals i n the normal course of 
life. 
"The valuable thing about ad-
ducts is their specificity," explained 
Ozonoff. "Suppose people are ex-
posed to chemicals like PCBs. You 
can do a regular epidemiological 
study and ask those exposed how 
they feel and what diseases they've 
had, and so on. But there are so 
many different factors that could ac-
count for their health problems that 
you can't single out the effects of 
the PCBs. 
"But if you could take blood sam-
ples, and see whether the PCBs are 
attached to their D N A , then even if 
there was only one person w i t h 
PCB-DNA adducts, you could iden-
tify that person." 
One major part of the research ef-
fort involves t ry ing to identify links 
between anti-cancer drugs and 
D N A from cancer patients. 
Since the main concern of the 
group is environmental contami-
nants, starting out w i t h a focus on 
drugs might seem curious. I n fact, 
though, the approach is entirely 
logical, said Cancer Center member 
John Groopman, Ph.D. , an assistant 
professor of environmental health 
and director of the DNA-adduct re-
search. 
"Many of these chemotherapeutic 
agents are very similar to the kinds 
of industrial chemicals you might 
f ind i n your water supply, or else-
where i n the environment," he ex-
plained. 
Moreover, most of them are 
toxic—some, i n fact, can themselves 
cause cancer. A n d by focusing on 
drugs, the investigators can get i n -
formation that w o u l d be unobtaina-
ble if they were looking at, say, ex-
posures to chemicals i n a dumpsite. 
Included, he said, is information 
about the exact dosages of specific 
drugs being given to patients. 
Using blood and urine samples 
from cancer patients w h o are under 
treatment elsewhere i n the country, 
Groopman and his associates have 
been searching for linkages between 
the patients' D N A and the drugs 
being used i n therapy. 
A t the same time, the investiga-
tors have been trying to determine 
whether they can predict how dif-
ferent individuals are going to re-
spond to particular drugs—an abil-
ity that, translated to the larger 
wor ld of environmental chemicals, 
might permit highly accurate predic-
tions about w h o is most vulnerable 
to particular kinds of toxic sub-
stances. 
Groopman noted that the work is 
in an early phase. Nevertheless, i n -
triguing signs have emerged that 
the DNA-adduct research w i l l signif-
icantly improve the understanding 
of how chemicals affect the human 
body. 
For example, said the toxicologist, 
he and his associates have discov-
ered that different patients have 
very different biochemical reactions 
to the same drug. 
"Each of us has a different capac-
ity to repair D N A , " said Groopman. 
"We have found that some of the 
patients receiving these chemothera-
peutic agents have an effective 
mechanism for repair—in other 
words, for eliminating the connec-
tions between their D N A and the 
d r u g . " 
Ironically, that is counterproduc-
tive when the chemical involved is ^ 
an anti-cancer drug. By repairing N _ 
the "damage" to their D N A , these 
patients reduce the drug's ability to 
destroy tumor cells. O n the other 
hand, if the chemical were, say, a 
cancer-causing agent i n food, such a 
repair capability could obviously be 
of great benefit to those w h o pos-
sessed it . 
I n talking about the long-term 
promise of the research, Groopman 
emphasized that the ability to iden-
tify links between D N A and chemi-
cals w o u l d not, i n and of itself, per-
mit accurate predictions about 
future cancer rates among people 
exposed to carcinogenic chemicals. 
Al though there is no question that 
damaged D N A can lead to cancer, 
very little is k n o w n about how, and 
how often, it happens. 
"But any interaction between a 
chemical and D N A , " said Groop-
man, "is potentially harmful to the 
individual , whether i t leads to can-
cer, to bir th defects or to any n u m -
ber of auto-immune diseases, such 
as rheumatoid arthritis. There are a 
great many diseases that have their 
origins i n damage to D N A . " 
While the D N A adduct research 
work may ultimately yield improved 
methods for gauging the harm done 
by environmental chemicals, i t w i l l 
not answer the question of h o w to 
prevent such harm. 
Today, the main avenue for m i n i -
mizing the impact of toxic chemicals 
on human health is to reduce expo-
sures: cutting d o w n the levels of 
chemicals i n foods, processing 
chemical wastes, introducing new 
cleanup technologies for dr inking 
water and so on. 
But what about those dangerous 
chemicals, such as PCBs, that are so 
widespread i n the environment that 
reducing exposures to very low lev-
els may simply not be feasible, at 
least i n the short term? 
Can vaccines against 
mrcinogens he created? 
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Frederick Moolten, M.D., discusses work related to development of anti-carcinogen vaccine. 
(Photo by Bradford F. Herzog.) 
Investigators at the Humphrey 
Center have embarked on a re-
search enterprise that, i n time, 
could provide a source of protection 
against such chemicals. Specifically, 
they are seeking to develop an anti-
carcinogen vaccine. 
The idea of a vaccine for chemi-
cally induced cancers is by no 
means as far-fetched as it may 
sound, said Frederick Moolten, 
M . D . , a Center member and an as-
sociate professor of microbiology. 
" A m i n o acids are the bui lding 
blocks for proteins, and our bodies 
are constantly producing new com-
binations of amino acids, which 
means we harbor a tremendous va-
riety of different proteins," ex-
plained Moolten. A m o n g the pro-
teins are many that can take on the 
role of antibody. This means they 
have the ability to "capture" alien 
substances that enter the body, and 
cause them either to be destroyed, 
or to be excreted along w i t h other 
bodily wastes. 
Since the potential number of dif-
ferent combinations of amino acids 
is so incredibly vast, added Mool-
ten, "the likelihood is very high that 
any foreign chemical, whether it oc-
curs i n nature or is synthetic, w i l l 
f ind someplace w i t h i n the body's 
repertoire of complex proteins an 
antibody w i t h which to react." 
In fact, he said, i t already has 
been shown that antibodies can be 
used to test l iv ing tissue for the 
presence of different kinds of chem-
icals. If the particular antibody 
k n o w n to " f i t " a specific chemical 
binds to the tissue i n elevated 
amounts, that signals that that 
chemical has collected there. 
To develop a vaccine, however, it 
is not enough simply to know that 
there are antibodies for specific en-
vironmental chemicals. Instead, 
some safe means must be found for 
building antibody levels, so that the 
body w i l l be forearmed i n case of 
exposure to the target chemicals. 
I n their quest for such a tech-
nique, Moolten and his associates 
have been focusing on a group of 
chemicals called polycylic aromatic 
hydrocarbons, or PAHs, many of 
which have been shown to cause 
cancer i n laboratory animals. 
The investigators' first series of 
experiments involved a chemical 
very similar to benzo(a)pyrene. This 
is one of the most common of the 
PAHs, and is found i n cigarette 
smoke, charcoal-broiled meat and 
diesel exhaust, among other places. 
The chemical that resembles 
benzo(a)pyrene was combined w i t h 
fluorine, to eliminate its cancer-
causing potential. That compound, 
i n turn , was chemically l inked to a 
large protein—a measure required, 
said the microbiologist, because by 
themselves chemicals like the PAHs 
cannot generate an antibody 
buildup i n human or animal tissues. 
"We first looked at the question 
of whether, if we gave rodents this 
compound and then exposed them 
to a P A H carcinogen, the animals 
w o u l d develop antibodies that 
w o u l d b ind to the carcinogen. 
" I n fact," continued Moolten, "we 
did f ind that compared to non-im-
munized animals, those that were 
immunized did develop antibodies, 
and were also more prone to excrete 
the carcinogen." 
The next step was to look at 
whether the immunized rodents 
were less prone to cancer than the 
non-immunized control group. 
"We've done some preliminary 
experiments," said Moolten, "and 
these indicate that the protected an-
imals do develop fewer tumors . " 
That, however, does not mean 
that a human vaccine against P A H -
induced cancers is just around the 
corner. Moolten said there are many 
questions to be answered before the 
notion of testing the compound i n 
humans could even be considered. 
For example: 
• Can the protective results be 
duplicated i n other animal experi-
ments? 
• H o w long does the protective 
effect of the compound last? 
• What is the best dose to give? 
• Is the vaccine effective against 
spontaneously occurring tumors as 
opposed to those generated i n the 
laboratory?; and, 
• Does the vaccine itself have 
harmful side effects? 
It w i l l take a long time and a lot 
of work to answer such questions, 
said Moolten. But if they can be an-
swered satisfactorily, he added, 
"then we could really start talking 
about the possibility of using vac-
cines like this to protect against 
spontaneously occuring tumors i n 
human b e i n g s . " • 
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Theodore Cotton, Sc.D., with slide showing advertisement for DES that appeared in a medi-
cal journal roughly 30 years ago. Legend at top of ad reads, "Death Strikes in Utero." 
(Photo by Bradford F. Herzog.) 
A scientist reflects on what it's like 
to tackle controversial research topics 
What does it mean for a scientist to 
have research interests that touch 
on emotionally felt concerns of the 
public at large? 
The question is of more than the-
oretical significance to Humphrey 
Center member Theodore Colton, 
Sc.D., a professor of socio-medical 
sciences and community medicine 
and chief of the Section on Biostatis-
tics and Epidemiology at BUSM's 
School of Public Health. 
A biostatistician by training. Col-
ton has had a hand i n studies i n t i -
mately l inked w i t h two major envi-
ronmental health controversies of 
recent decades—one related to the 
role of prescription drugs i n causing 
cancer, and the second to the role 
of low-level radiation i n causing the 
disease. 
I n neither case has his involve-
ment propelled him. into the na-
tional limelight—there have been no 
appearances on the Merv Cr i f f in 
Show, and no profiles i n People 
magazine—and that, says Colton, 
suits h i m fine. O n the other hand, 
his work has given h i m firsthand 
exposure to what happens when 
scientific research becomes the focus 
of public controversy. 
The first of the environmental-
health controversies i n which Col-
ton played a part related to the can-
cer-causing properties of the drug 
diethylstilbesterol (DES), which at 
one time was thought to reduce the 
risk of spontaneous abortions. 
The biostatistician was involved 
i n the original study indicating that 
daughters of women w h o took DES 
had a heightened chance of being 
afflicted by vaginal cancer. 
That study, published more than 
a decade ago, triggered a public de-
bate not just about w h o was to 
blame, but about the whole issue of 
the government's role i n protecting 
consumers against potentially dan-
gerous drugs. 
While the debate over DES has 
died d o w n , studies of the drug's ef-
fects continue. For example, Colton 
today is involved i n a project aimed 
at f inding out how the drug has af-
fected the child-bearing capabilities 
of the DES daughters. 
"We recently published a paper i n 
the New England Journal of Medicine 
i n which we reported that DES 
daughters seem to have a higher 
risk of adverse pregnancy out-
comes—more miscarriages, still-
births and premature babies—than 
women w h o were not exposed to 
the d r u g , " says the biostatistician. 
The f inding doesn't mean DES-ex-
posed women cannot have healthy, 
full-term babies, he adds. They can, 
and most of the time do. Their 
chances of a problem pregnancy, 
though, are greater than those of 
non-exposed women. 
The shipyard controversy 
Meanwhile, the biostatistician still 
is experiencing the aftereffects of 
the other major environmental-
health issue i n which he played a 
part: the nuclear-shipyard contro-
versy. 
I n the late 1970s, Colton was 
asked by an acquaintance w h o was 
a hematologist to help analyze data 
on cancer-related deaths among 
workers at the Portsmouth Naval 
Shipyard i n Kittery, Maine, where 
nuclear submarines are repaired. He 
agreed. 
" I helped h i m put the data to-
gether and analyze i t , " says Colton, 
"and the analysis seemed to show 
that the workers at the shipyard 
who were exposed to low-level ra-
diation had a higher frequency of 
mortality f rom cancer than the non-
exposed workers ." 
Since the Navy was unwi l l ing to 
make the workers' radiation expo-
sure records available, the informa-
tion to which the investigators had 
access was incomplete, and as a 
consequence, their findings were 
tentative. I n reporting their results, 
Colton and his colleague were care-
ful to note this point. 
As sometimes happens w i t h envi-
ronmental-health studies dealing 
w i t h controversial matters, though. 
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the results appeared first, not i n a 
medical journal, but i n newspapers. 
Predictably, the investigators' warn-
ings about the gaps i n their infor-
mation were lost i n a swirl of media 
reports about "Nuclear shipyard 
workers dying of cancer." A n t i - n u -
clear activists seized on the reports 
as a new weapon i n their battle 
against nuclear power. Pro-nuclear 
groups attacked the study for what 
they described as its weaknesses, 
often failing to note that Colton and 
his fellow investigator, Thomas Na-
jarian, M . D . , had themselves 
pointed out the study's limitations. 
Meanwhile, both sides distorted the 
investigators' f indings. 
For example, says Colton, "the 
study has been very much mis-
quoted as saying that there were el-
evated death rates among the n u -
clear workers. We said nothing 
about death rates. A l l we said was 
that, of the shipyard workers at 
Portsmouth Naval Shipyard w h o 
had died, there seemed to be an ex-
cess of deaths from cancer among 
those w i t h radiation exposure." 
Prepared to take risks 
Despite the distortions and at-
tacks to which the study has been 
subject, Colton says he has no re-
grets about his involvement i n the 
project. Indeed, he is convinced 
that scientists must be prepared to 
venture into rough seas, if that is 
where their investigations lead 
them. 
"One of the difficulties we face 
today is that we're dealing w i t h 
many issues where the degree of i n -
creased risk is very small ," says the 
biostatistician. 
" I f you're analyzing the connec-
tion between smoking and cancer, 
there's no problem," says Colton, 
"because smokers are at a much 
greater risk of cancer than non-
smokers—it's on the order of be-
tween ninefold and thirteenfold." 
W i t h low-level radiation, by con-
trast, the exposed workers might 
have no more than one-and-a-half 
to two times the cancer risk of their 
co-workers—a level that simply can-
not generate the kinds of statistics 
that w o u l d remove all doubt about 
the radiation-cancer l ink. 
Dealing w i t h subjects like these, 
where findings hover at the lower 
bounds of statistical significance, 
has its hazards, says Colton. He 
strongly disagrees, however, w i t h 
those w h o say studies like that of 
the shipyard workers should not be 
published. 
" I f you are cautious," says the 
biostatistician, "and make sure to 
indicate very clearly i n your paper 
what the problems are, and to as-
sert that the results need further 
verification and further study—as 
we did i n our shipyard paper—then 
I very definitely th ink that you 
should publish. 
"Look at i t this w a y , " he contin-
ues. "Suppose you're doing a 
study, and you've reached some 
tentative conclusions; and suppose 
you know that the study is going to 
have tremendous public impact and 
may become the basis for many 
lawsuits: What do you do about it? 
"From my perspective, i t w o u l d 
be a far worse th ing to suppress 
this information than to publish i t . I 
think it needs to be published, and 
to be disseminated w i t h i n the scien-
tific community, if for no other rea-
son than to try to inspire further 
study. " • 
BRIEFLY N O T E D 
New equipment donated 
A i d for Cancer Research, a Bos-
ton-area volunteer group, has do-
nated a H i g h Performance Liquid 
Chromatography system to the lab-
oratory of Herbert H . Wotiz, Ph.D. , 
deputy director and research coordi-
nator of the Cancer Center. 
The equipment is dedicated to 
Selma Aronson of Brookline, Mass., 
a member of A i d for Cancer Re-
search for 32 years. The dedication 
was made dur ing ceremonies held 
A p r i l 6 at the School of Medicine. 
Wotiz, whose research interests 
include the role of hormones i n the 
development of cancer of the breast 
and the prostate, said the system 
w i l l greatly enhance his group's 
ability to probe the biochemistry of 
hormonal effects on internal organs. 
A i d for Cancer Research has been 
a longtime supporter of research by 
Humphrey Center members. Its 
most recent previous donation was 
the equipping of the Center's H y b r i -
doma Laboratory, which produces 
antibodies used i n a wide variety of 
research enterprises.• 
Selma Aronson, center, was on hand recently when new chromatography system for labora-
tory of Herbert H. Wotiz, Ph.D., Cancer Center deputy director, was dedicated in her 
honor. Also pictured are her husband, William, far left; Miriam Horwitz, president of Aid 
for Cancer Research, donors of the equipment, second from left; Wotiz; and Phyllis Frank, 
dedication chairperson of ACR. 
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Laurence Corwin, Ph.D. 
1929-1983 
Cancer Center member Laur-
ence M . Corwin , Ph.D. , a pro-
fessor of microbiology and n u -
tritional sciences, died Feb. 21 
of lymphoma. He was 53. 
Corwin was an authority on 
vitamin E and its relationship 
to the development of cancer. 
A t the time of his death he 
was involved i n research proj-
ects aimed at confirming ear-
lier studies indicating that the 
vitamin helps reduce cancer 
risk. 
Center Director Paul H . 
Black, M . D . , said Corwin was 
not only a highly capable and 
accomplished investigator but 
also was an outstanding 
teacher. "He was so interested 
i n the welfare of his students 
that he w o u l d spend endless 
hours advising t h e m , " Black 
said. 
Corwin received his Ph.D. 
from Wayne State University 
i n Detroit i n 1967. He joined 
the BUSM faculty i n 1967 and 
was named a f u l l professor i n 
1973. He became a member of 
the Cancer Center i n 1980. 
L^uoperuuna symposium 
The Fourth Annual Sidney R. 
Cooperband Symposium, devoted 
this year to research i n progress at 
the Hubert H . Humphrey Cancer 
Research Center, was held May 13 
at University Hospital. 
The symposium, which honors 
the memory of the Cancer Center's 
first director, featured a fu l l day of 
presentations on various aspects of 
the research program. Covered i n 
the talks by more than 20 Center 
members were topics ranging from 
the external structures of cells, and 
how these may relate to tumor de-
velopment, to the use of antibodies 
to slow the spread of cancer i n 
blood cells. Center Director Paul H . 
Black, M . D . , presided. 
Previous symposia have featured 
talks on various subjects f rom ex-
perts from outside the Cancer Cen-
ter. Herbert H . Wotiz, Ph.D. , dep-
uty director and research coordin-
ator for the Center, said there were 
two principal reasons for featuring 
talks by Center members this year: 
to give the broader Boston Univer-
sity Medical Center community a 
chance to learn about the Center's 
research program, and to encourage 
more interchange and collaboration 
among Center members. • 
\cscarcii grunt awards 
Two Cancer Center members are 
recipients of this year's research 
grants f rom the Whitaker Health 
Sciences Fund, a private foundation 
based at the Massachusetts Institute 
of Technology (MIT) that supports 
collaborative projects involving fac-
ulty f rom M I T and various Boston 
medical schools. 
Center members chosen for the 
prestigious awards were Richard 
Bell, M . D . , an assistant professor of 
medicine, for a project entitled " O n -
cogene Expression i n H u m a n Tu-
mors"; and Edward W. Schroder, 
Ph.D., an assistant professor of m i -
crobiology, for a project on "Altera-
tion of Cell Surface Intercellular 
Communications and Reversal of 
the Cancer Phenotype by Vitamin 
A . " Each grant is for the sum of 
$36,000. • 
Conference on AiUb 
Center Director Paul H . Black, 
M . D . , was among 34 experts invited 
to discuss the Acquired Immune 
Deficiency Syndrome (AIDS) epi-
demic at a Washington, D.C. , meet-
ing convened by the National Insti-
tute for Allergy and Infectious 
Diseases i n A p r i l . 
The syndrome is a mysterious ail-
ment i n which the body's immune 
system loses its ability to defend 
against a wide variety of ailments, 
including a form of cancer k n o w n 
as Kaposi's sarcoma. It has been 
most prevalent among male homo-
sexuals, Haitian immigrants and 
drug addicts. • 
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